MBX Biosciences, Inc. (MBX)
31.66
+0.94
(+3.06%)
USD |
NASDAQ |
Jan 09, 16:00
31.64
-0.02
(-0.06%)
After-Hours: 20:00
MBX Biosciences Shareholders Equity (Quarterly): 387.54M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 79.28B |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| Insmed, Inc. | 945.57M |
| ARS Pharmaceuticals, Inc. | 147.66M |
| Aardvark Therapeutics, Inc. | 122.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 400.08M |
| Total Liabilities (Quarterly) | 12.54M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 32.95 |
| Net Debt Paydown Yield | -0.01% |